Effects of two-months balanced diet in metabolically healthy obesity: lipid correlations with gender and BMI-related differences

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Rondanelli, Mariangela ^a   Klersy, Chaterine ^b   Perna, Simone ^a   Faliva, Milena Anna ^a   Montorfano, Gigliola ^c   Roderi, Paola ^c   Colombo, Irma ^c   Corsetto, Paola Antonia ^c   Fioravanti, Marisa ^a   Solerte, Sebastiano Bruno ^a   Rizzo, Angela Maria ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Balance diet; Desaturase activities; Fatty acid profile; Metabolically healthy obesity

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ADIPONECTIN; ARACHIDONIC ACID; C REACTIVE PROTEIN; CHOLESTEROL; DOCOSAHEXAENOIC ACID; GHRELIN; GLUCAGON LIKE PEPTIDE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LEPTIN; LINOLEIC ACID; LINOLEOYL COENZYME A DESATURASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; ADIPOQ PROTEIN, HUMAN; CARBOHYDRATE DIET; DELTA-5 FATTY ACID DESATURASE; FAT INTAKE; PROTEIN INTAKE; UNSATURATED FATTY ACID;

ADULT; ARTICLE; ATHEROGENIC INDEX OF PLASMA; BALANCED DIET; BODY BUILD; BODY COMPOSITION; BODY MASS; CLINICAL EFFECTIVENESS; CORRELATIONAL STUDY; DIET THERAPY; ENZYME ACTIVITY; FAT MASS; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID COMPOSITION; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLICALLY HEALTHY OBESITY; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; SEX DIFFERENCE; THERAPY EFFECT; ADMINISTRATION AND DOSAGE; BLOOD; CARBOHYDRATE DIET; DIET; FAT INTAKE; METABOLISM; OBESITY, METABOLICALLY BENIGN; PROTEIN INTAKE;

ADIPONECTIN; ADULT; ARACHIDONIC ACID; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; FATTY ACID DESATURASES; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; FEMALE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN RESISTANCE; LEPTIN; LINOLEIC ACID; MALE; MIDDLE AGED; OBESITY, METABOLICALLY BENIGN; SEX FACTORS; TRIGLYCERIDES;

EID: 84946033864     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0131-1     Document Type: Article

References (54)

1. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol. 2010;21:38-43.
2. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30:569-72.
3. Hashimoto Y, Tanaka M, Okada H, Senmaru T, Hamaguchi M, Asano M, et al. Metabolically Healthy Obesity and Risk of Incident CKD. Clin J Am Soc Nephrol. 2015;10:578-83.
4. Heianza Y, Arase Y, Tsuji H, Fujihara K, Saito K, Hsieh SD, et al. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). J Clin Endocrinol Metab. 2014;99:2952-60.
5. Appleton S, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36:2388-94.
6. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97:2482-8.
7. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, KIhan U, Wildman RP. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring). 2012;20:651-9.
8. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J. 2013;34:389-97.
9. St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, Després JP, et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CAMJ. 2005;172:1301-5.
10. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care. 2006;29:404-9.
11. Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring). 2010;18:911-7.
12. Messier V, Karelis AD, Robillard ME, Bellefeuille P, Brochu M, Lavoie JM, et al. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism. 2010;59:20-4.
13. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90:4145-50.
14. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol. 2003;14:15-9.
15. Storlien LH, Hulbert AJ, Else PL. Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity. Curr Opin Clin Nutr Metab. 1998;1:559-63.
16. Nakamura MT, Nara TY. Structure, function, and dietary regulation of Δ6, Δ5, and Δ9 desaturases. Ann Rev Nutr. 2004;24:345-76.
17. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A. 2002;99:11482-6.
18. Ntambi JM, Young-Cheul K. Regulation of StearoylCoA desaturase genes by dietary fat: role of PUFAs. In: Berdanier CD, Moustaid-Moussa N, editors. CRC series in modern nutrition: nutrient-gene interactions in health and disease. 1980. p. 49-58.
19. Warensjo E, Ohrvall M, Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis. 2006;16:128-36.
20. Vessby B, Unsitupa M, Hermansen K. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001;44:312-9.
21. Summers LK, Fielding BA, Bradshaw HA. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002;45:369-77.
22. Katan MB, Deslyper JP, van Birgelen AP, Penders M, Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res. 1997;38:2012-22.
23. Dougherty RM, Galli C, Ferro-Luzzi A, Iacono JM. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am J Clin Nutr. 1987;45:443-55.
24. Cooper AM, Michels R. Diagnostic and statistical manual of mental disorders, revised (DSM-III-R). Am J Psych. 1988;145:1300-1.
25. Kamel EG, McNeill G, Van Wijk MC. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res. 2000;8:36-42.
26. Frisancho AR. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr. 1984;40:808-19.
27. American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31:S61-78.
28. Wylie-Rosett J, Albright AA, Apovian C, Clark NG, Delahanty L, Franz MJ, et al. 2006-2007 American Diabetes Association. Nutrition Recommendations: issues for practice translation. J Am Diet Assoc. 2007;107:1296-304.
29. Davis NJ, Emerenini A, Wylie-Rosett J. Obesity management: physician practice patterns and patient preference. Diabetes Educ. 2006;32:557-61.
30. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996;19:1138-41.
31. Onat A, Can G, Kaya H, Hergenç G. "Atherogenic index of plasma" (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 2010;4:89-98.
32. Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7:e39504.
33. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
34. Corsetto PA, Cremona A, Montorfano G, Jovenitti IE, Orsini F, Arosio P, et al. Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation. Cell Biochem Biophys. 2012;64:45-59.
35. Rizzo AM, Montorfano G, Negroni M, Adorni L, Berselli P, Corsetto P, et al. A rapid method for determining arachidonic: eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies. Lipids Health Dis. 2010;9:7.
36. Mayneris-Perxachs J, Guerendiain M, Castellote AI, Estruch R, Covas MI, Fitó M, et al. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. Clin Nutr. 2014;33:90-7.
37. Kröger J, Schulze MB. Recent insights into the relation of Δ5 desaturase and Δ6 desaturase activity to the development of type 2 diabetes. Curr Opin Lipidol. 2012;23:4-10.
38. Dalzill C, Nigam A, Juneau M, Guilbeault V, Latour E, Mauriège P, et al. Intensive lifestyle intervention improves cardiometabolic and exercise parameters in metabolically healthy obese and metabolically unhealthy obese individuals. Can J Cardiol. 2014;30:434-40.
39. Ruiz JR, Ortega FB, Labayen I. A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese ad metabolially healthy but obese premenopausal women. Ann Nutr Metab. 2013;62:223-30.
40. Cambien F, Warnet JM, Vernier V, Ducimetière P, Jacqueson A, Flament C, et al. An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factors in middle-aged men. Am J Epidemiol. 1988;127:75e86.
41. Vessby B, Gustafsson IB, Tengblad S, Berglund L. Indices of fatty acid desaturase activity in healthy human subjects: effects of different types of dietary fat. Br J Nutr. 2013;110:871-9.
42. Warensjo E, Riserus U, Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia. 2005;48.
43. Warensjo E, Sundstrom J, Vessby B, Cederholm T, Risérus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population based study. Am J Clin Nutr. 2008;88:203-9.
44. Do HJ, Chung HK, Moon J, Shin MJ. Relationship between the estimates of desaturase activities and cardiometabolic phenotypes in Koreans. J Clin Biochem Nutr. 2011;49:131-5.
45. Gray RG, Kousta E, McCarthy MI, Godsland IF, Venkatesan S, Anyaoku V, et al. Ethnic variation in the activity of lipid desaturases and their relationships with cardiovascular risk factors in control women and an at-risk group with previous gestational diabetes mellitus: a cross-sectional study. Lipids Health Dis. 2013;12:25.
46. Pan DA, Lilloja S, Milner MR, Kriketos AD, Baur LA, Bogardus C, et al. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest. 1995;96:2802-8.
47. Murakami K, Sasaki S, Takahashi Y, Uenishi K, Watanabe T, Kohri T, et al. Lower estimates of d-5 desaturase and elongase activity are related to adverse profiles for several metabolic risk factors in young Japanese women. Nutr Res. 2008;28:816-24.
48. Warensjo E, Rosell M, Hellenius ML, Vessby B, De Faire U, Risérus U. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis. 2009;8:37.
49. Paillard F, Catheline D, Duff FL, Bouriel M, Deugnier Y, Pouchard M, et al. Plasma palmitoleic acid, a product of stearoyl-CoA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis. 2008;18:436-40.
50. Klein SL. Immune cells have sex and so should journal articles. Endocrinology. 2012;153:2544-50.
51. Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2014;111:869-74.
52. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2:777-80.
53. Wendell SG, Baffi C, Holguin F. Fatty acids, inflammation, and asthma. J Allergy Clin Immunol. 2014;133:1255-64.
54. Kunesová M, Phinney S, Hainer V, Tvrzická E, Stich V, Parízková J, et al. The responses of serum and adipose Fatty acids to a one-year weight reduction regimen in female obese monozygotic twins. Ann N Y Acad Sci. 2002;967:311-23.